TrialInternational journal of molecular sciences2018

Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles.

Anna Sobuś et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.